IP Verse

Site-Directed Modification Of Fviii

Patent No. EP2772500 (titled "Site-Directed Modification Of Fviii") was filed by Bayer Healthcare on Nov 14, 2005. The application was issued on Dec 25, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MARKS & CLERKDec 27, 2019MARKS & CLERK

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2772500

BAYER HEALTHCARE
Application Number
EP14165736A
Filing Date
Nov 14, 2005
Status
Revoked
Aug 19, 2022
Publication Date
Dec 25, 2019
External Links
Slate, Register , Google Patents